Evidence map›Paper›PMID 32789744›Full record

ReviewApplied microbiology and biotechnology2020

Industrial biotechnology of Pseudomonas putida: advances and prospects.

Anna Weimer, Michael Kohlstedt, Daniel C Volke, Pablo I Nikel, Christoph Wittmann

Abstract readReview
In one paragraph

Review in Applied microbiology and biotechnology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 112 papers.

0numbers the graph read from it
0cells of the map it votes in
112citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

112 citing papers in PubMed.

  1. New microbes and new infections · 2026
    Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Multi-layered metabolic remodeling ofMetabolic engineering communications · 2026
    Article
  8. Article
  9. Article
  10. EngineeringACS synthetic biology · 2026
    Article
  11. Multi-strain analysis ofmSystems · 2026
    Article
  12. Emergence of outbreak-driving high-riskMicrobial genomics · 2026
    Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Going beyond size: exploring the metabolic burden inSynthetic biology (Oxford, England) · 2026
    Article
  19. Advances in microbial biosynthesis of indirubin.Chinese herbal medicines · 2026
    Review
  20. Review

52 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Anna WeimerInstitute of Systems Biotechnology, Saarland University, Campus A1.5, 66123, Saarbrücken, Germany.
Michael KohlstedtInstitute of Systems Biotechnology, Saarland University, Campus A1.5, 66123, Saarbrücken, Germany.
Daniel C VolkeThe Novo Nordisk Foundation Center for Biosustainability, Technical University of Denmark, Lyngby, Denmark.
Pablo I NikelThe Novo Nordisk Foundation Center for Biosustainability, Technical University of Denmark, Lyngby, Denmark.
Christoph WittmannInstitute of Systems Biotechnology, Saarland University, Campus A1.5, 66123, Saarbrücken, Germany. christoph.wittmann@uni-saarland.de.ORCID http://orcid.org/0000-0002-7952-985X

Funding

Bundesministerium für Bildung und Forschung 031B0344ABundesministerium für Bildung und Forschung 03V0757Danish Council for Independent Research 8021-00039BHorizon 2020 814418Local Government of Saarland NINANovo Nordisk Fonden NNF10CC1016517Novo Nordisk Fonden NNF18OC0034818
6 · The paper itself

Abstract

Pseudomonas putida is a Gram-negative, rod-shaped bacterium that can be encountered in diverse ecological habitats. This ubiquity is traced to its remarkably versatile metabolism, adapted to withstand physicochemical stress, and the capacity to thrive in harsh environments. Owing to these characteristics, there is a growing interest in this microbe for industrial use, and the corresponding research has made rapid progress in recent years. Hereby, strong drivers are the exploitation of cheap renewable feedstocks and waste streams to produce value-added chemicals and the steady progress in genetic strain engineering and systems biology understanding of this bacterium. Here, we summarize the recent advances and prospects in genetic engineering, systems and synthetic biology, and applications of P. putida as a cell factory. KEY POINTS: • Pseudomonas putida advances to a global industrial cell factory. • Novel tools enable system-wide understanding and streamlined genomic engineering. • Applications of P. putida range from bioeconomy chemicals to biosynthetic drugs.

Indexed as

Pseudomonas putidaBiotechnologyGenomicsSynthetic BiologySystems BiologyBacterial chassisBiocatalysisBioeconomyBiotransformationEDEMP cycleKT2440LigninMetabolic engineeringMicrobial cell factoryPHAPseudomonas putidaSynthetic biology

Identifiers

PMID32789744
PMCPMC7447670

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.